Demand for Hypertrophic Cardiomyopathy Therapeutics Expected to Increase Post Approval of Novel Drug Health Articles | August 16 Yao Inter Milan Jersey , 2016
Transparency Market Research Report Added "Hypertrophic Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends Mauro Icardi Inter Milan Jersey , and Forecast 2015 - 2023"
The global hypertrophic cardiomyopathy (HCM) therapeutics market is dominated by companies exhibiting high sales. However, generic manufacturers are making their presence felt in the market gradually. As per Transparency Market Research (TMR), the top three companies in the market, Sanofi S.A., Pfizer, Inc. Roberto Gagliardini Inter Milan Jersey , and Merck & Co., accounted for a share of over 64.5%, which points toward a highly consolidated vendor landscape.聽
Get Free Sample Research Report:
Intense competition exists among the top companies in the market. These enterprises are mainly focusing on expanding and differentiating their product portfolio to enjoy sustainable growth.
Demand for HCM Therapeutics Surges due to Increasing Incidence of Congestive Heart Failure
“The prevalence of chronic cardiovascular ailments is fueling demand for effective treatment, which has been translating into lucrative sales opportunities for hypertrophic cardiomyopathy therapeutics,” said a lead TMR analyst. Heart diseases make one of the most common causes of death in both men and women around the world. According to TMR, the rising incidence of congestive heart failure considerably fuels demand for effective medications. This creates attractive opportunities for sales of hypertrophic cardiomyopathy therapeutics.
"Besides this Samir Handanovic Inter Milan Jersey , successful interventions conducted across several countries to spread awareness about hypertrophic cardiomyopathy have also aided the expansion of the HCM therapeutics market,” said the TMR analyst. Furthermore, patients are now more aware about the latest medical advances, which augurs well for the market. ECG screening is the most efficient technology for diagnosing HCM. The success demonstrated by this technology has significantly contributed in fuelling demand for HCM therapeutics.
Rising Penetration of Advanced Medical Devices to Threaten Market Growth
Despite witnessing positive growth opportunities, the rising penetration of medical devices such as pacemakers and defibrillators in the healthcare sector has been inhibiting the HCM therapeutics market’s trajectory. Demand for gene therapy and implantable medical devices is rising as patients gain adequate knowledge about positive results offered by such advanced medical devices. The increasing acceptance of these medical devices could limit the scope of expansion for the HCM therapeutics market.
Nevertheless, drugs created specifically for the treatment of hypertrophic cardiomyopathy are yet to find approval. Once approved Authentic Fredy Guarin Jersey , this indication will bolster sales opportunities for the market players. Additionally, due to the high prevalence of unmet medical needs across Asia Pacific and the increasing medical expenditure in the region also boosts prospects for the HCM therapeutics market.
Regionally, North America holds the largest share in the global HCM therapeutics market. However, as per TMR, the market is also expected to witness strong growth in Asia Pacific and Rest of the World. The Asia Pacific HCM therapeutics market is poised to expand at 2.9% CAGR between 2015 and 2023. By drug class, the market was led by calcium channel blockers in 2014. By drug class Authentic Ivan Perisic Jersey , the calcium channel blockers is expected to dominate the market. It held over 37.4% of the HCM therapeutics market in 2014.
TMR estimates the overall value of the global hypertrophic cardiomyopathy therapeutics market at US$1.2 bn in 2014. Exhibiting a moderate CAGR of 1.4% from 2015 to 2023, the market is expected to reach US$1.3 bn by the end of 2023.
This review is based on information published by TMR, in a report titled “Hypertrophic Cardiomyopathy Therapeutics (HCM) Market - Global Industry Analysis, Pipeline Analysis, Size, Share Authentic Joao Mario Jersey , Growth, Trends, and Forecast, 2015 – 2023.”
Browse Research Report on Global Hypertrophic Cardiomyopathy Therapeutics Market:
EKAYANA Media is a professional communications corporation geared towards a global platform. With a highly qualified team passionate in their craft and dedicated to your success, we are your partners in creating a company poised to compete on the dynamic world stage.
Ekayana, whose meaning of ’One path’ is derived from the ancient language of Pali Authentic Miranda Jersey , embodies our philosophy of being the one-stop solution for all communication needs. Our expertise lies in our comprehensive integrated solutions of web consultancy, content development, creative design and conference support for both private and public sectors.
With a deep-rooted mandate in service, our creative consultants and technicians strive our best to utilize cutting-edge technologies that reach out to a global audience. At Ekayana Media, we take constant pride in customizing professional and creative solutions that will be instrumental in propelling your business to greater heights.
Equipped with the skills to provide integrated communication services for all manner of industries, Ekayana Media has had particular depth of experience in doing communications for microfinance institutions. With a thorough understanding of the microfinance industry Authentic Nemanja Vidic Jersey , Ekayana Media is the ideal partner to bridge the distance between you and your customer.
DieNamenlosen
Thema drucken
02.01.2020 06:53
Antworten
